This website uses cookies to ensure you get the best experience. Learn more about DOAJ’s privacy policy.
Hide this message
Качественная клиническая практика (Oct 2020)
Affiliations
Read online
Use of canakinumab in patients with COVID-19 is currently lacking proper evidence base, and should not be recommended outside of clinical trials.